Bay Area startup delivers clinical trials analytics from the cloud

Comprehend Systems is riding the cloud-computing wave in drug development. The Palo Alto, CA-based startup has announced a cloud-based version of its software for analyzing and visualizing clinical trial data.

A year after debuting the software, the company wants to make adoption of the Comprehend Clinical product seamless. And the cloud-based software complements the existing theme at the company to provide analytics and visualization of clinical trials data without complex integration and changes to existing infrastructure. For instance, the company lets CROs and pharma groups use one tool to analyze the information from multiple disparate data sources from different vendors.

With the cloud-based software, the company has added a hosted option that allows users to further distance themselves from IT management hassles. The cloud software provides speedy and secure analysis of data from multiple clinical trials, Comprehend says, with a menu of additional capabilities, such as embedding the tool on an existing website or key software platform, such as SharePoint. And the company is targeting users of leading clinical trials platforms, such as Medidata Rave and Oracle Clinical with the analytics, visualization and reporting tool.

"While sponsors today have access to some of the best clinical research systems available--like Medidata Rave and Oracle Clinical--most are still frustrated by the lack of powerful, easy-to-use analytics and insight into their data, and might not have the time or resources to undertake another infrastructure deployment," Comprehend CEO Rick Morrison said in a statement. "By also offering Comprehend Clinical as a cloud-based solution, we're giving research organizations the option to become empowered by the analytics they need through their existing clinical systems with little to no IT intervention."

- here's the release

Special Report: Comprehend Clinical - 5 emerging biotech IT firms to watch

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.